Skip to content

Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD

The Affiliated Eye Hospital of Wenzhou Medical University

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03968575
Enrollment
20
Registered
2019-05-30
Start date
2019-04-01
Completion date
2022-04-30
Last updated
2021-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drusen

Brief summary

To investigate the efficacy and safety of sub-threshold micro-pulse laser therapy for drusen of dry age-related macular degeneration (AMD) .

Interventions

DEVICElaser treatment

sub-threshold micro-pulse laser treatment

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Older than 50 years of age. 2. Male or female patients with nonexudative AMD with a drusen diameter of at least 125um in the central 3mm circle 3. clear media to perform colour, red-free imaging and fundus fluorescein angiography, fundus autofluorescence imaging and OCT. 4. Able to give an informed consent.

Exclusion criteria

1. Presence of other macular disease such as epiretinal membrane, macular telangiectasia. 2. unclear media that no clear colour, red-free imaging and fundus fluorescein angiography, fundus autofluorescence imaging and OCT can performed. 3. Ocular or periocular infections.

Design outcomes

Primary

MeasureTime frameDescription
Change in macular drusen volume6 and 12 monthsMean change in macular drusen volume on optical coherence tomograph(OCT)
Change in macular drusen area6 and 12 monthsMean change in macular drusen area on OCT

Secondary

MeasureTime frameDescription
Change in visual acuity6 and 12 monthsMean change in best-corrected visual acuity

Countries

China

Contacts

Primary ContactYing Huang
wzhuangying@163.com0577-88068855

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026